Two candidate genes that are of potential interest in clinical genetics of breast cancer are SMAD3 and SMAD4, encoding the key signaling transduction proteins of the Transforming Growth Factor-β (TGF-β) pathway. Here, SMAD4 is linked to breast cancer.